Univar files for IPO
This article was originally published in The Rose Sheet
Industrial chemical distributor has filed with U.S. Securities and Exchange Commission to raise up to $862.5 million in an initial public offering of common stock. Univar distributes chemicals for use in moisturizing lotions, shampoos, body washes and coloring and styling products. The personal-care market accounted for 5% of Redmond, Wash.-based firm's $7.2 billion net sales in 2009
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.